MD4900B1 - Compoziţie farmaceutică de pancreatină şi procedeu de preparare a acesteia - Google Patents

Compoziţie farmaceutică de pancreatină şi procedeu de preparare a acesteia Download PDF

Info

Publication number
MD4900B1
MD4900B1 MDA20220054A MD20220054A MD4900B1 MD 4900 B1 MD4900 B1 MD 4900B1 MD A20220054 A MDA20220054 A MD A20220054A MD 20220054 A MD20220054 A MD 20220054A MD 4900 B1 MD4900 B1 MD 4900B1
Authority
MD
Moldova
Prior art keywords
pharmaceutical composition
preparation process
pancreatin
pancreatin pharmaceutical
oral
Prior art date
Application number
MDA20220054A
Other languages
English (en)
Russian (ru)
Other versions
MD4900C1 (ro
MD20220054A2 (ro
Inventor
Санджив ГУПТА
Раджив ГУПТА
Тг ЧАНДРАШЕКХАР
Свати МУКХЕРДЖИ
Винит БХАРДВАДЖ
Викас БАЛИ
Original Assignee
Kusum Healthcare Private Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kusum Healthcare Private Limited filed Critical Kusum Healthcare Private Limited
Publication of MD20220054A2 publication Critical patent/MD20220054A2/ro
Publication of MD4900B1 publication Critical patent/MD4900B1/ro
Publication of MD4900C1 publication Critical patent/MD4900C1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Invenţia se referă la o compoziţie farmaceutică solidă pentru administrare orală de pancreatină şi la un procedeu de preparare a acesteia. Compoziţia farmaceutică orală solidă, preparată prin procedeul, descris în prezenta invenţie, este, de asemenea, stabilă atunci când este supusă testării stabilităţii la temperatura de 30°C şi umiditatea relativă (RH) de 75% pentru o perioadă de cel puţin trei luni.
MDA20220054A 2020-06-10 2021-06-10 Compoziţie farmaceutică de pancreatină şi procedeu de preparare a acesteia MD4900C1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202011024325 2020-06-10
PCT/IN2021/050563 WO2021250700A1 (en) 2020-06-10 2021-06-10 Pharmaceutical composition of pancreatin

Publications (3)

Publication Number Publication Date
MD20220054A2 MD20220054A2 (ro) 2023-05-31
MD4900B1 true MD4900B1 (ro) 2024-08-31
MD4900C1 MD4900C1 (ro) 2025-03-31

Family

ID=78846986

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20220054A MD4900C1 (ro) 2020-06-10 2021-06-10 Compoziţie farmaceutică de pancreatină şi procedeu de preparare a acesteia

Country Status (5)

Country Link
MD (1) MD4900C1 (ro)
MX (1) MX2022014395A (ro)
PH (1) PH12022553091A1 (ro)
UA (1) UA129226C2 (ro)
WO (1) WO2021250700A1 (ro)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3025528B2 (ja) * 1989-11-24 2000-03-27 ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング パンクレアチン製剤
CA2619477C (en) * 2005-08-15 2015-05-26 Solvay Pharmaceuticals Gmbh Pancreatin micropellet cores suitable for enteric coating

Also Published As

Publication number Publication date
WO2021250700A1 (en) 2021-12-16
MD4900C1 (ro) 2025-03-31
PH12022553091A1 (en) 2023-10-16
MX2022014395A (es) 2022-12-02
MD20220054A2 (ro) 2023-05-31
UA129226C2 (uk) 2025-02-12

Similar Documents

Publication Publication Date Title
HUP0204235A2 (hu) Helyettesített glutárimidek és felhasználásuk IL-12 termelés inhibitorként, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
CY1109457T1 (el) Παραγωγο aminoαλκοολης ή παραγωγο φωσφονικου οξεος και φαρμακευτικη συνθεση που τα περιεχει
BR112022000431A2 (pt) Derivados de 2-morfolinopiridina substituídos como inibidores da atr cinase
Chen et al. Cytotoxic effects of denture adhesives on primary human oral keratinocytes, fibroblasts and permanent L 929 cell lines
CY1105528T1 (el) Παρασκευaσματα σταθεροποιημeνα για μακρo διaστημα
BR0307893A (pt) Formulação oftálmica com sistema de goma
BR112022003046A2 (pt) Conjugados de il-15 e usos dos mesmos
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
ATE32728T1 (de) Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel.
ATE308327T1 (de) Verwendung von 2-hydroxy-5-phenylazobenzoesäure- derivaten als wirkstoffe zur chemoprävention und chemotherapie von kolonkrebs
BRPI0916936B8 (pt) composições farmacêuticas, uso de clevidipina e método de reduzir impurezas.
BRPI0410219A (pt) composições farmacêuticas de vareniclina
AR125250A1 (es) Composiciones de psilocibina, procedimientos de fabricación y procedimientos de uso de las mismas
DK1931316T3 (da) Farmaceutiske sammensætninger med kontrolleret afgivelse til syrelabile lægemidler
AU2412695A (en) Taxane class derivative based pharmaceutical compositions
BRPI0507830A (pt) derivados azabicìclicos, o respectivo processo de preparo e as composições farmacêuticas que os contêm
DE69033970D1 (de) Huperzin a analoge verbindungen
EE200100104A (et) 5-HT4 agonisti või antagonisti uus peroraalne ravimvorm
RU2008139633A (ru) Лекарственные композиции, содержащие фторхинолоны
BRPI0606606A2 (pt) composições estáveis contendo prostaglandina
NO20051018L (no) Farmasoytisk preparat inneholdende en benzimidazolforbindelse blandet med mikrokrystallinsk cellulose og en fremgangsmate for fremstilling derav
MD4900B1 (ro) Compoziţie farmaceutică de pancreatină şi procedeu de preparare a acesteia
BR0318242A (pt) derivados de azabiciclo hexano substituìdo como antagonistas de receptores muscarìnicos e processo para sua preparação
MD20220032A2 (ro) Compoziţie farmaceutică de S-adenozilmetionină

Legal Events

Date Code Title Description
FG4A Patent for invention issued